ExecuPharm Holding Company Inc., a leading, global functional service provider (FSP) serving the biopharmaceutical industry, completed the sale of 100% of its company stock to PAREXEL International Corp., a publicly-traded strategic buyer. Our firm represented ExecuPharm Holding Company in the transaction.
October 2016
ExecuPharm Holding Company Completes Sale to PAREXEL
United States - Pennsylvania
Lead Contacts
